Vertex Pharmaceuticals said it would seek regulatory approval for one of its experimental cystic-fibrosis drugs after the treatment helped improve patients’ lung function in late-stage studies.
WSJ.com: Health, Wall Street Journal: Business: Health
Tue, 03/28/2017 - 3:26pm
Vertex Pharmaceuticals said it would seek regulatory approval for one of its experimental cystic-fibrosis drugs after the treatment helped improve patients’ lung function in late-stage studies.